Heart Disease News and Research

Latest Heart Disease News and Research

Changes needed in orthopedic training programs, but restrictions and generational differences compromise learning experience

Changes are needed in the programs that train orthopedic surgeons to ensure these doctors are adequately trained, according to a study by researchers at Hospital for Special Surgery (HSS) in New York City.

5 Jan 2010

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine.

5 Jan 2010

ART publishes impressive data on its bioresorbable stent

Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company’s approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.

5 Jan 2010

New chemoprevention therapy for skin cancer

People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.

5 Jan 2010

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

5 Jan 2010

Study examines relationship between parental vaccine refusal and risk of varicella infection in children

Children of parents who refuse vaccines are nine times more likely to get chickenpox compared to fully immunized children, according to a new study led by a vaccine research team at Kaiser Permanente Colorado's Institute for Health Research.

5 Jan 2010

Book reveals new evidence of obesity-causing chemicals in American diet

The New American Diet, a groundbreaking new book by Men’s Health Editor-at-Large Stephen Perrine and Heather Hurlock, reveals the powerful new scientific evidence about obesity-causing chemicals lurking in the American diet – chemicals that disrupt our hormonal systems ultimately triggering substantial weight gain.

5 Jan 2010

H1N1 vaccine available at Walgreens pharmacies and Take Care Clinics

Every Walgreens pharmacy, every day. The once-scarce H1N1 vaccine is now available daily at all of the more than 7,100 Walgreens pharmacies and 350 Take Care Clinics throughout the country.

5 Jan 2010

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.

5 Jan 2010

Montana high court allows physician-assisted suicide

The Associated Press/NPR reports: "The Montana Supreme Court said Thursday that nothing in state law prevents patients from seeking physician-assisted suicide, making Montana the third state that will allow the procedure. Patients and doctors had been waiting for the state's high court to step in after a lower court decided a year ago that constitutional rights to privacy and dignity protect the right to die. The Montana Supreme Court opinion will now give doctors in the state the freedom to prescribe the necessary drugs to mentally competent, terminally ill patients without fear of being prosecuted, advocates said" (1/2).

5 Jan 2010

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

5 Jan 2010

Headline results from first phase III study of Balaglitazone announced

Dr. Reddy’s Laboratories Ltd. and Rheoscience, a subsidiary of Nordic Bioscience A/S, today announced the headline results from the first phase III study for their investigational agent, Balaglitazone.

4 Jan 2010

Pfizer's Revatio solution for injection receives European Commission approval

Pfizer Inc. announced today that the European Commission has approved Revatio® (sildenafil) solution for injection for patients who are currently prescribed oral Revatio and who are temporarily unable to take oral medicine, but are otherwise clinically and haemodynamically stable.

4 Jan 2010

Tactx Medical acquired by Creganna

Creganna, a leading supplier of technologies and services to medical device and lifesciences companies today announced that it has acquired Avalon Medical Services Pte Ltd. which trades as Tactx Medical Inc.

4 Jan 2010

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

4 Jan 2010

Physicians raise concerns about proposed Medicare changes

The health care legislation being considered by Congress seeks to reform Medicare and look for alternatives to the fee-for-service payment system, which critics say discourages care coordination and quality. American Medical News reports on one alternative called bundling, in which "doctors and hospitals are paid for all services to a patient in an episode of care for a particular condition.

4 Jan 2010

Cardiogenesis submits an IDE for its PHOENIX System

Cardiogenesis Corporation, today announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.

4 Jan 2010

Sunlighten to unveil mPulse Series in April 2010

Sunlighten(TM) (www.sunlighten.com) is proud to unveil its mPulse(TM) Series, set to launch in April 2010, which is the world's first sauna with personalized biofeedback tracking as well as customizable full spectrum infrared heat that targets specific health concerns.

4 Jan 2010

Cardima receives Shonin approval from the Japanese MHLW to market PATHFINDER catheters

Cardima, Inc., a medical device company focused on the diagnosis and treatment of atrial fibrillation (AF), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to re-enter the Japanese market with its family of guidewire-based, multi-electrode PATHFINDER® diagnostic mapping catheters.

4 Jan 2010

North Carolina takes historic step for health with the implementation of smoke-free law

North Carolina on January 2 will take an historic step for health when it becomes the first major tobacco-growing state to implement a statewide smoke-free law that includes all restaurants and bars. This new law will protect the right of North Carolinians to breathe clean air.

4 Jan 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Changes needed in orthopedic training programs, but restrictions and generational differences compromise learning experience

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

ART publishes impressive data on its bioresorbable stent

New chemoprevention therapy for skin cancer

VELCADE sNDA receives FDA approval

Study examines relationship between parental vaccine refusal and risk of varicella infection in children

Book reveals new evidence of obesity-causing chemicals in American diet

H1N1 vaccine available at Walgreens pharmacies and Take Care Clinics

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

Montana high court allows physician-assisted suicide

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

Headline results from first phase III study of Balaglitazone announced

Pfizer's Revatio solution for injection receives European Commission approval

Tactx Medical acquired by Creganna

DSPA submits lurasidone NDA to the FDA

Physicians raise concerns about proposed Medicare changes

Cardiogenesis submits an IDE for its PHOENIX System

Sunlighten to unveil mPulse Series in April 2010

Cardima receives Shonin approval from the Japanese MHLW to market PATHFINDER catheters

North Carolina takes historic step for health with the implementation of smoke-free law

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in